Patient Adherence to Secondary Prevention Therapies After an Acute Coronary Syndrome: A Scoping Review

Authors: Bahit, M. Cecilia, Korjian, Serge, Daaboul, Yazan, Baron, Suzanne, Bhatt, Deepak L., Kalayci, Arzu, Chi, Gerald, Nara, Paul, Shaunik, Alka, Gibson, C. Michael

Source: In Clinical Therapeutics November 2023 45(11):1119-1126

Barriers and facilitators to implementation of intravenous cardiovascular treatments in ambulatory settings.

Authors: Jalloh, Mohamed B., Osoro, Ian, Januzzi, James L., Shaunik, Alka, Bahit, M. Cecilia, Korjian, Serge, Gibson, C. Michael, Van Spall, Harriette G.C.

Source: ESC Heart Failure; Feb2025, Vol. 12 Issue 1, p695-700, 6p

Effectiveness of premixed insulin to achieve glycaemic control in type 2 diabetes: A retrospective UK cohort study

Authors: Jude, Edward B., Trescoli, Carlos, Emral, Rifat, Ali, Amar, Lubwama, Robert, Palmer, Karen, Shaunik, Alka, Nanda, Nithya, Raskin, Philip, Gomez‐Peralta, Fernando

Source: Diabetes, obesity & metabolism. 23(4):929-937

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100133096896.0x000001&indx=1&recIds=ETOCvdc_100133096896.0x000001

Gastrointestinal adverse events with insulin glargine/lixisenatide fixed‐ratio combination versus glucagon‐like peptide‐1 receptor agonists in people with type 2 diabetes mellitus: A network meta‐analysis

Authors: Rayner, Christopher K., Wu, Tongzhi, Aroda, Vanita R., Whittington, Craig, Kanters, Steve, Guyot, Patricia, Shaunik, Alka, Horowitz, Michael

Source: Diabetes, obesity & metabolism. 23(1):136-146

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100124373028.0x000001&indx=1&recIds=ETOCvdc_100124373028.0x000001

Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims data

Authors: Beachler, Daniel C., Taylor, Devon H., Anthony, Mary S., Yin, Ruihua, Li, Ling, Saltus, Catherine W., Li, Lin, Shaunik, Alka, Walsh, Kathleen E., Rothman, Kenneth J., Johannes, Catherine B., Aroda, Vanita R., Carr, Warner, Goldberg, Pinkus, Accardi, Andrew, O'Shura, John Shane, Sharma, Kristen, Juhaeri, Juhaeri, Lanes, Stephan, Wu, Chuntao

Source: Pharmacoepidemiology and drug safety. 30(7):918-926

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100122968630.0x000001&indx=1&recIds=ETOCvdc_100122968630.0x000001

Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin‐treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomized controlled trial

Authors: McCrimmon, Rory J., Al Sifri, Saud, Emral, Rifat, Mohan, Viswanathan, Sauque‐Reyna, Leobardo, Trescolí, Carlos, Lalic, Nebojsa, Alvarez, Agustina, Demil, Nacima, Coudert, Mathieu, Shaunik, Alka, Bonnemaire, Mireille, Rosenstock, Julio

Source: Diabetes, obesity & metabolism. 23(6):1221-1231

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100120638532.0x000001&indx=1&recIds=ETOCvdc_100120638532.0x000001

Efficacy and safety of iGlarLixi versus IDegLira in adults with type 2 diabetes inadequately controlled by glucagon‐like peptide‐1 receptor agonists: a systematic literature review and indirect treatment comparison

Authors: Home, Philip D., Aroda, Vanita R., Blonde, Lawrence, Guyot, Patricia, Shaunik, Alka, Fazeli, Mir Sohail, Goswami, Hardik, Kalra, Sanjay, Pourrahmat, Mir‐Masoud

Source: Diabetes, obesity & metabolism. 22(11):2170-2178

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100111609985.0x000001&indx=1&recIds=ETOCvdc_100111609985.0x000001

Insulin glargine/lixisenatide fixed‐ratio combination (iGlarLixi) compared with premix or addition of meal‐time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta‐analysis

Authors: Home, Philip, Blonde, Lawrence, Kalra, Sanjay, Ji, Linong, Guyot, Patricia, Brulle‐Wohlhueter, Claire, Murray, Erin, Shah, Roshan, Sayre, Toby, Shaunik, Alka

Source: Diabetes, obesity & metabolism. 22(11):2179-2188

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100111610011.0x000001&indx=1&recIds=ETOCvdc_100111610011.0x000001

Understanding Reasons for Treatment Discontinuation, Attitudes and Education Needs Among People Who Discontinue Type 2 Diabetes Treatment: Results from an Online Patient Survey in the USA and UK

Authors: Roborel de Climens, Aude, Pain, Emilie, Boss, Anders, Shaunik, Alka

Source: Diabetes therapy. 11(8):1873-1881

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100172272902.0x000001&indx=1&recIds=ETOCvdc_100172272902.0x000001

† Evaluating the Residual Risk of Recurrent Cardiovascular Events in Contemporary Cardiovascular Outcomes Trials

Authors: Serge, Korjian, Daaboul, Yazan, Bhatt, Deepak, Ridker, Paul M, Yeh, Robert W, Mehran, Roxana, Baron, Suzanne, Libby, Peter, Chi, Gerald, Kalayci, Arzu, Nara, Paul, Shaunik, Alka, Gibson, C Michael

Source: Journal of clinical lipidology. 17(S):e1-e2

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100195755042.0x000001&indx=1&recIds=ETOCvdc_100195755042.0x000001

Achievement of glycaemic control is associated with improvements in lipid profile with iGlarLixi versus iGlar: A post hoc analysis of the LixiLan‐L trial

Authors: Giorgino, Francesco, Shaunik, Alka, Liu, Minzhi, Saremi, Aramesh

Source: Diabetes, obesity & metabolism. 21(12):2712-2717

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100092314731.0x000001&indx=1&recIds=ETOCvdc_100092314731.0x000001

Evaluating Glycemic Control in Patients with Type 2 Diabetes Suboptimally Controlled on Basal Insulin: UK ATTAIN Real-World Study

Authors: Jude, Edward B., Nixon, Mark, O'Leary, Caroline, Myland, Melissa, Gooch, Nick, Shaunik, Alka, Lew, Elisheva

Source: Diabetes therapy. 10(5):1847-1858

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100187139432.0x000001&indx=1&recIds=ETOCvdc_100187139432.0x000001

Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA

Authors: Blonde, Lawrence, Meneghini, Luigi, Peng, Xuejun Victor, Boss, Anders, Rhee, Kyu, Shaunik, Alka, Kumar, Supriya, Balodi, Sidhartha, Brulle-Wohlhueter, Claire, McCrimmon, Rory J.

Source: Diabetes therapy. 9(3):1347-1358

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100130472802.0x000001&indx=1&recIds=ETOCvdc_100130472802.0x000001

Glucagon-like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Naïve Patients with Type 2 Diabetes Mellitus: A Multinational Preference Study

Authors: Qin, Lei, Chen, Stephanie, Flood, Emuella, Shaunik, Alka, Romero, Beverly, Cruz, Marie, Alvarez, Cynthia, Grandy, Susan

Source: Diabetes therapy. 8(2):321-334

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100117605470.0x000001&indx=1&recIds=ETOCvdc_100117605470.0x000001

Glucagon-Like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Experienced Patients with Type 2 Diabetes Mellitus: A Preference Study in Germany and the United Kingdom

Authors: Qin, Lei, Chen, Stephanie, Flood, Emuella, Shaunik, Alka, Romero, Beverly, Cruz, Marie, Alvarez, Cynthia, Grandy, Susan

Source: Diabetes therapy. 8(2):335-353

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100117605386.0x000001&indx=1&recIds=ETOCvdc_100117605386.0x000001

† Cholesterol Efflux Capacity in Patients with or without Type 2 Diabetes Mellitus: A Meta-Analysis

Authors: Chi, Gerald, Lee, Jane J, Montazerin, Sahar Memar, Korjian, Serge, Vitarello, Clara, Shaunik, Alka, Gibson, C Michael

Source: Journal of clinical lipidology. 17(S):e33-e33

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100195754712.0x000001&indx=1&recIds=ETOCvdc_100195754712.0x000001

THE ECONOMIC AND HUMANISTIC BURDEN OF MULTIVESSEL DISEASE IN ACUTE MYOCARDIAL INFARCTION: A SYSTEMATIC REVIEW

Authors: Korjian, Serge, Bahit, Maria Cecilia, Daaboul, Yazan, Chi, Gerald, Karabay, Arzu Kalayci, Gabriel, Susan, Cupples, Gemma, Fazeli, Mir Sohail, Shaunik, Alka, Gibson, C. Michael

Source: Journal of the American College of Cardiology. 81(S):1317-1317

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100195319987.0x000001&indx=1&recIds=ETOCvdc_100195319987.0x000001

Response to letter to the editor regarding 'Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims data'

Authors: Beachler, Daniel C., Taylor, Devon H., Anthony, Mary S., Yin, Ruihua, Li, Ling, Saltus, Catherine W., Li, Lin, Shaunik, Alka, Walsh, Kathleen E., Rothman, Kenneth J., Johannes, Catherine B., Aroda, Vanita R., Carr, Warner, Goldberg, Pinkus, Accardi, Andrew, O'Shura, John Shane, Sharma, Kristen, Juhaeri, Juhaeri, Lanes, Stephan, Wu, Chuntao

Source: Pharmacoepidemiology and drug safety. 31(1):110-111

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100139137891.0x000001&indx=1&recIds=ETOCvdc_100139137891.0x000001

Association of Cholesterol Efflux Capacity with Adverse Cardiovascular Outcomes: A Meta-Analysis†

Authors: Lee, Jane J., Chi, Gerald, Fitzgerald, Clara, Kazmi, Syed Hassan, Korjian, Serge, Duffy, Danielle, Shaunik, Alka, Kingwell, Bronwyn, Yeh, Robert, Bhatt, Deepak, Gibson, C.

Source: Journal of clinical lipidology. 16(S):e1-e2

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100158352547.0x000001&indx=1&recIds=ETOCvdc_100158352547.0x000001

Evaluating glycaemic control in patients poorly controlled on oral antidiabetic drugs in real‐world setting: Results from assessing the Appropriate Timing of Type 2 diAbetes INtensification (ATTAIN)

Authors: Jude, Edward B., O'Leary, Caroline, Myland, Melissa, Nixon, Mark, Gooch, Nick, Shaunik, Alka, Lew, Elisheva

Source: Endocrinology, diabetes & metabolism. 3(1)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100099776184.0x000001&indx=1&recIds=ETOCvdc_100099776184.0x000001